Company comparison
Deep Genomics vs Ansys
Radar profile, momentum bars, and stack placement side by side.
Deep Genomics
Not scored
momentum
Ansys
Not scored
momentum
Deep Genomics capital
—
Ansys capital
—
No radar series.
Momentum head-to-head
Attribute tape
| Field | Deep Genomics | Ansys |
|---|---|---|
| Category | Vertical applications | Vertical applications |
| Stack | Layer 9 | Layer 9 |
| HQ | Toronto, Ontario, Canada | Canonsburg, PA, United States |
| Founded | 2014 | 1970 |
| Status | Operating | Acquired |
| Funding | — | — |
| Momentum | — | — |
| Summary | Deep Genomics is an AI therapeutics company that applies machine learning to RNA biology to discover and develop genetic medicines for genetically defined diseases. Its AI Workbench platform and BigRNA foundation model identify novel RNA-based therapeutic targets and candidates that traditional methods cannot readily find. | Ansys develops engineering simulation software spanning structural mechanics, computational fluid dynamics, electromagnetics, and optics, enabling engineers to validate product designs digitally before physical prototyping. As of 2025, Ansys operates as a subsidiary of Synopsys following its acquisition. |
| Who for | Teams evaluating AI vendors in this category. | Teams evaluating AI vendors in this category. |
| Differentiator | Deep Genomics is an AI therapeutics company that applies machine learning to RNA biology to discover and develop genetic medicines for genetically defined diseases. Its AI Workbench platform and BigRNA foundation model identify novel RNA-based therapeutic targets and candidates that traditional methods cannot readily find. | Ansys develops engineering simulation software spanning structural mechanics, computational fluid dynamics, electromagnetics, and optics, enabling engineers to validate product designs digitally before physical prototyping. As of 2025, Ansys operates as a subsidiary of Synopsys following its acquisition. |
